Pinned post
Nature features epigenetic editing as “CRISPR’s next act.” For me, this story reflects a 12-year scientific arc that began with repurposing CRISPR as a non-cutting platform, dCas9, CRISPRi/a, and is now moving toward epigenetic medicines.
Proud of the @EpicrisprBio team!
nature.com/articles/d4158…
Proud of the @EpicrisprBio team!
nature.com/articles/d4158…